SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc

Bullboard Posts

Comment by WileyCyteon Jan 20, 2018 10:10am

70 Views

Post# 27400364

RE:Quantification ?

I couldn't agree more with your post MM. While I do see it as a positive, SQD has made it un-necessarily difficult for SHs to properly guage just how positive, by not releasing any figures. So unfortunately this is likely another very nominal gain on the balance sheet - perhaps they are being paid $150,000 for the assay work?
Overall, revenue of any significance continues to elude this company. Bit frustrating. Their news releases are incredibly underwhelming. Makes me wonder if their biz model and products are sound.

Bullboard Posts

The Market Online’s Weekly Cannabis Report – Nov. 15, 2024